1
|
Rahmanian E, Alikhani M, Loghman M, Beikmohamadi Hezaveh S, Zangeneh S, Shahriarirad R, Faezi ST, Nejadhosseinian M. COVID
‐19
vaccine‐induced
vasculitis in a patient with sarcoidosis: A case report. Clin Case Rep 2022; 10:e6501. [DOI: 10.1002/ccr3.6501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Revised: 09/29/2022] [Accepted: 10/09/2022] [Indexed: 12/05/2022] Open
Affiliation(s)
- Ehsan Rahmanian
- Department of Rheumatology Hormozgan University of Medical Sciences Bandar Abbas Iran
| | - Majid Alikhani
- Department of Internal Medicine, School of Medicine, Rheumatology Research Center, Shariati Hospital Tehran University of Medical Sciences Tehran Iran
| | - Maryam Loghman
- Department of Internal Medicine, School of Medicine, Rheumatology Research Center, Shariati Hospital Tehran University of Medical Sciences Tehran Iran
| | - Sara Beikmohamadi Hezaveh
- Resident of Neurology, Department of Neurology, Shariati Hospital Tehran University of Medical Sciences Tehran Iran
| | - Saba Zangeneh
- School of Medicine Fasa University of Medical Sciences Shiraz Iran
| | - Reza Shahriarirad
- School of Medicine Shiraz University of Medical Sciences Shiraz Iran
- Thoracic and Vascular Surgery Research Center Shiraz University of Medical Sciences Shiraz Iran
| | - Seyedeh Tahereh Faezi
- Department of Internal Medicine, School of Medicine, Rheumatology Research Center, Shariati Hospital Tehran University of Medical Sciences Tehran Iran
| | - Mohammad Nejadhosseinian
- Joint Reconstruction Research Center Tehran University of Medical Sciences Tehran Iran
- Rheumatology Research Center Tehran University of Medical Sciences Tehran Iran
| |
Collapse
|
2
|
Mohseni Afshar Z, Tavakoli Pirzaman A, Liang JJ, Sharma A, Pirzadeh M, Babazadeh A, Hashemi E, Deravi N, Abdi S, Allahgholipour A, Hosseinzadeh R, Vaziri Z, Sio TT, Sullman MJM, Barary M, Ebrahimpour S. Do we miss rare adverse events induced by COVID-19 vaccination? Front Med (Lausanne) 2022; 9:933914. [PMID: 36300183 PMCID: PMC9589063 DOI: 10.3389/fmed.2022.933914] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2022] [Accepted: 09/13/2022] [Indexed: 11/13/2022] Open
Abstract
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused many complications, the invention of coronavirus disease 2019 (COVID-19) vaccines has also brought about several adverse events, from common side effects to unexpected and rare ones. Common vaccine-related adverse reactions manifest locally or systematically following any vaccine, including COVID-19 vaccines. Specific side effects, known as adverse events of particular interest (AESI), are unusual and need more evaluation. Here, we discuss some of the most critical rare adverse events of COVID-19 vaccines.
Collapse
Affiliation(s)
- Zeinab Mohseni Afshar
- Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | | | - Jackson J. Liang
- Division of Cardiovascular Medicine, Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, MI, United States
| | - Akanksha Sharma
- Department of Neurology, Mayo Clinic, Scottsdale, AZ, United States
| | - Marzieh Pirzadeh
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran
| | - Arefeh Babazadeh
- Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
| | - Erfan Hashemi
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran
| | - Niloofar Deravi
- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Sadaf Abdi
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran
| | - Amirreza Allahgholipour
- Student Research Committee, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Rezvan Hosseinzadeh
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran
| | - Zahra Vaziri
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran
| | - Terence T. Sio
- Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States
| | - Mark J. M. Sullman
- Department of Social Sciences, University of Nicosia, Nicosia, Cyprus
- Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus
| | - Mohammad Barary
- Student Research Committee, Virtual School of Medical Education and Management, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
| | - Soheil Ebrahimpour
- Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
| |
Collapse
|
3
|
Yuan L, Fan L, Mao Q, Luan X, Wang Z, Zeng N, Cheng Y, Li Y, Xia Q, Lu Z, Lu Q, Min W, Luo D. Clinical Observation and Analysis of Skin Reactions Caused by
COVID
‐19 Vaccination. Dermatol Ther 2022; 35:e15746. [DOI: 10.1111/dth.15746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2022] [Revised: 05/09/2022] [Accepted: 07/20/2022] [Indexed: 12/01/2022]
Affiliation(s)
- Li Yuan
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
- Dermatology Department The Fifth People's Hospital of Hainan Province Haikou China
| | - Lipan Fan
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Qiuyu Mao
- Department of Dermatology First Affiliated Hospital of Soochow University Suzhou China
| | - Xingbao Luan
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Zhaopeng Wang
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Ni Zeng
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Yuxin Cheng
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Yueyue Li
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Qingyue Xia
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Zhiyu Lu
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Qian Lu
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| | - Wei Min
- Department of Dermatology First Affiliated Hospital of Soochow University Suzhou China
| | - Dan Luo
- Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China
| |
Collapse
|
4
|
Tripathy DM, Kumar S, Saraswat N, Goel S, Ranjan E. Post herpetic granulomatous dermatitis and herpes zoster necroticans triggered by Covid-19 vaccination. Dermatol Ther 2022; 35:e15707. [PMID: 35811450 PMCID: PMC9350396 DOI: 10.1111/dth.15707] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Revised: 06/18/2022] [Accepted: 07/08/2022] [Indexed: 11/30/2022]
Affiliation(s)
| | - Sushil Kumar
- Dermatology, Motilal Nehru Medical College, Allahabad, India
| | | | | | | |
Collapse
|
5
|
|
6
|
Cutaneous Reactions to COVID-19 Vaccines in a Monocentric Study: A Case Series. J Clin Med 2022; 11:jcm11133811. [PMID: 35807096 PMCID: PMC9267144 DOI: 10.3390/jcm11133811] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2022] [Revised: 06/24/2022] [Accepted: 06/27/2022] [Indexed: 02/07/2023] Open
Abstract
After coronavirus disease 2019 (COVID-19) caused a global pandemic, vaccines were rapidly developed to control the spread of the virus. Although they were effective in most of the cases at protecting people from becoming seriously ill and being hospitalized, they showed side effects, too. Among other adverse vaccine reactions, cutaneous eruptions following SARS-CoV-2 have been described in the literature, but they are not well-characterized yet. We described the morphology and timing of the spectrum of cutaneous reactions following most of the COVID-19 vaccines available in Italy, which were observed in outpatients referred to our non-invasive diagnostic clinic. Most of these reactions appeared after the second or third COVID-19 vaccine dose (most of them after mRNA COVID-19 vaccines). Our data support that cutaneous reactions to COVID-19 vaccination are generally self-limited; in addition, history of allergic reaction to a specific food, medicine or vaccine should not discourage vaccination in the general population, although patients with immune dysregulation should be accurately selected and monitored. Further research is necessary to better assess the true prevalence and preventive measures of skin reactions to COVID-19 vaccination.
Collapse
|
7
|
Sadeghi S, Amini Z, Goodarzi A. A Comparative Review on Mucocutaneous Reactions Caused by Covid-19 Infection versus Covid-19 Vaccination. Exp Dermatol 2022; 31:1122-1127. [PMID: 35657119 PMCID: PMC9348341 DOI: 10.1111/exd.14620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2022] [Revised: 03/27/2022] [Accepted: 05/31/2022] [Indexed: 11/29/2022]
Abstract
IMPORTANCE The prevalence and severity of mucocutaneous manifestations in Covid-19 infection are generally higher than those reported in Covid vaccines. Therefore, comparing the mucocutaneous reactions of the Covid-19 infection and vaccination is necessary to enhance our knowledge about such reactions and guide us to evaluate the risk of infection or vaccination. OBSERVATION A thorough literature search was conducted on PubMed, Google Scholar, and EBSCO (LISTA), and 2,069 articles were downloaded. After screening, 11 studies remained for the final review. The literature review revealed that the prevalence and severity of post-vaccine mucocutaneous adverse reactions have been less common compred to Covid-19 infection. Post-vaccine adverse reactions primarily occurred after the first dose administration and such reactions were manageable with antihistamines and corticosteroids administration. CONCLUSIONS AND RELEVANCE The current comparative analysis highlights the frequency and potential severity of mucocutaneous reactions due to Covid-19 infection and Covid-19 vaccination. It also affirmed that potentially critical (serious) mucocutaneous reactions are more likely to occur in Covid-19 infection compared to Covid vaccination. Moreover, post-vaccine reactions predominantly happened after the first dose and were reported to be non-life-threatening, self-manageable, and with a lower incidence of potentially critical events. It was also concluded that the incidence of mucocutaneous reactions decreased in the following doses. Hence, given the low rate of such reactions following Covid-19 vaccination, vaccines have a lower risk of mucocutaneous reactions occurrence than Covid-19 infection. Further, due to the limited number of studies, we recommend that large-scale trials evaluate such reactions comparing various types of Covid-19 vaccines in healthy individuals and those with autoimmune skin disorders.
Collapse
Affiliation(s)
- Sara Sadeghi
- Department of Pediatrics, Division of Dermatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada.,Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - Zeynab Amini
- School of Biology and Environmental Science, Queensland University of Technology, Brisbane, Australia
| | - Azadeh Goodarzi
- Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
8
|
Afacan E, Edek YC, İlter N, Gülekon A. Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center. Int J Dermatol 2022; 61:626-627. [PMID: 35080255 DOI: 10.1111/ijd.16086] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Revised: 12/02/2021] [Accepted: 01/05/2022] [Indexed: 12/17/2022]
Affiliation(s)
- Elif Afacan
- Department of Dermatology, Faculty of Medicine, Gazi University, Ankara, Turkey
| | - Yusuf C Edek
- Department of Dermatology, Faculty of Medicine, Gazi University, Ankara, Turkey
| | - Nilsel İlter
- Department of Dermatology, Faculty of Medicine, Gazi University, Ankara, Turkey
| | - Ayla Gülekon
- Department of Dermatology, Faculty of Medicine, Gazi University, Ankara, Turkey
| |
Collapse
|
9
|
Kim Y, Kim YC. Wells' syndrome following Oxford-AstraZeneca COVID-19 vaccination. J Eur Acad Dermatol Venereol 2022; 36:e328-e330. [PMID: 35015930 DOI: 10.1111/jdv.17916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Revised: 12/07/2021] [Accepted: 01/07/2022] [Indexed: 11/28/2022]
Affiliation(s)
- Yulhee Kim
- Department of Dermatology, Ajou University, School of Medicine, Suwon, Korea
| | - You Chan Kim
- Department of Dermatology, Ajou University, School of Medicine, Suwon, Korea
| |
Collapse
|
10
|
Ayatollahi A, Hosseini H, Firooz R, Firooz A. COVID-19 vaccines: What dermatologists should know? Dermatol Ther 2021; 34:e15056. [PMID: 34232548 PMCID: PMC8420198 DOI: 10.1111/dth.15056] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Revised: 06/30/2021] [Accepted: 07/05/2021] [Indexed: 12/12/2022]
Abstract
As COVID‐19 vaccination has started worldwide to control this pandemic, dermatologists may face various challenges with these new vaccines. In this manuscript, we review different types of available COVID‐19 vaccines and their various production platforms. Vaccination considerations in patients with skin diseases, especially those using immunomodulatory drugs will be presented. Finally, adverse cutaneous reactions of COVID‐19 vaccines will be reviewed.
Collapse
Affiliation(s)
- Azin Ayatollahi
- Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran
| | - Hamed Hosseini
- Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran
| | - Rojin Firooz
- Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran
| | - Alireza Firooz
- Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|